Novo Nordisk Signs MOU With China's Health Ministry To Launch Patient Education Programs
This article was originally published in The Pink Sheet Daily
Executive Summary
Novo Nordisk's newest move to increase patient education in China will cost RMB 9 million over three years, a small price to pay to reinvigorate growth slowed by insulin price cuts.